Heart device maker Edwards Lifesciences Corp. says it expects a sales boost from new and current products to drive double-digit earnings growth in 2010.
The company says it expects profit between $3.50 and $3.60 per share on revenue between $1.43 billion and $1.5 billion in 2010. The outlook represents up to 18 percent growth in earnings per share.
Analysts polled by Thomson Reuters expect $3.53 per share in profit on $1.42 billion in revenue in 2010.
The company says it expects to launch its new Sapien XT transcatheter valve in Europe during the first quarter. Meanwhile, it says recent product launches have been driving surgical valve sales and the momentum is expected to continue into 2010.
Latest from Today's Medical Developments
- Exchangeable-head solid carbide cutting tools
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
